Neuberger High Yield Fund Launches Rights Offering to Raise Capital

  • Neuberger High Yield Strategies Fund (NHS) announced a rights offering on March 12, 2026, with a record date of March 23, 2026.
  • Stockholders will receive transferable rights to subscribe for additional shares at a discount to market price.
  • The subscription price will be determined on April 15, 2026, based on a formula tied to the average market price or NAV.
  • The offering aims to raise capital to capitalize on investment opportunities and improve the fund's expense ratio.

Neuberger High Yield Strategies Fund is leveraging a rights offering to expand its asset base, a move that aligns with broader trends in closed-end funds seeking to capitalize on market opportunities. The strategy aims to improve the fund's expense ratio and liquidity, reflecting a focus on operational efficiency in the asset management sector. With $563 billion in AUM, Neuberger Berman is positioning NHS to take advantage of high-yield debt securities in a dynamic market.

Capital Deployment
How effectively NHS will deploy the new capital to enhance long-term returns.
Market Conditions
Whether the current market environment will support the fund's investment strategy.
Investor Response
The level of participation in the rights offering and its impact on NHS's liquidity.